Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo
Novartis Pharmaceuticals
Ankylosing Spondylitis
1 trial -
Placebo
Eli Lilly and Company
Hepatocellular Carcinoma
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Adult Attention Deficit Hyperactivity Disorder
1 trial -
Placebo
SUPERNUS PHARMACEUTICALS, INC.
ADHD
5 trials -
Placebo
AbbVie
Psoriatic Arthritis
1 trial -
Placebo
AbbVie
Rheumatoid Arthritis
1 trial -
Placebo
Ark Therapeutics
Hyperphagia
1 trial -
Placebo
AbbVie
Ulcerative Colitis (UC)
2 trials -
Placebo
Takeda
Non-erosive Gastroesophageal Reflux Disease
1 trial -
Placebo
Biogen
Multiple Sclerosis, Remittent Progressive
1 trial -
Placebo
Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
1 trial -
Placebo
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Placebo
Disc Medicine
Erythropoietic Protoporphyria (EPP)
1 trial -
Placebo
Pfizer
Ulcerative Colitis
1 trial -
Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Schizoaffective Disorder
1 trial -
Placebo
Alnylam Netherlands B.V.
Primary Hyperoxaluria Type 1 (PH1)
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Schizophrenia
2 trials -
Placebo
AstraZeneca
Irritable Bowel Syndrome With Constipation (IBS-C)
1 trial -
Placebo
Sanofi Pasteur
Colorectal Neoplasms
1 trial -
Placebo
Takeda
Generalized Anxiety Disorder
1 trial -
Placebo
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Fatty Liver Disease
1 trial -
Placebo
Hoffmann-La Roche
Schizophrenia
1 trial -
Placebo
Milestone Pharmaceuticals
Atrial Fibrillation
1 trial -
Placebo
Takeda
Lennox Gastaut Syndrome (LGS)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.